Previewing Upcoming Opt-Out Decisions And Player Options
With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.
Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.
Note: All stats referenced are through play Sunday
Elite Potential Free Agents
- Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)
Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.
That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).
On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).
- Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)
Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.
Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).
There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.
- Xander Bogaerts, Red Sox SS (can opt out of final three years and $60MM)
Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.
One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.
- Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)
There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.
deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.
- Justin Verlander, Astros RHP ($25MM option for 2023)
While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.
Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.
Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.
The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.
- Carlos Rodón, Giants LHP ($22.5MM option for 2023)
We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.
Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.
Quality Regulars Likely To Opt Out
- Anthony Rizzo, Yankees 1B ($16MM option for 2023)
Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.
That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.
- Jurickson Profar, Padres LF ($8.5MM option, $1MM buyout)
The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.
Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.
Starting Pitchers With High Buyouts
- Taijuan Walker, Mets RHP ($6MM option, $3MM buyout)
Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.
Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.
- Jake Odorizzi, Braves RHP ($12.5MM option, $6.25MM buyout)
Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.
Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).
Easy Calls To Return
- Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)
Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.
- Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)
Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.
- Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)
Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.
- AJ Pollock, White Sox LF ($11MM option, $5MM buyout)
The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.
The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.
- Jonathan Schoop, Tigers 2B ($7.5MM option)
Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.
- Charlie Blackmon, Rockies DH/RF ($12MM option)
Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.
The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.
Relievers
- Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)
Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.
Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.
- Andrew Chafin, Tigers LHP ($6.5MM option)
Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.
That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.
- Robert Suárez, Padres RHP ($5MM option, $1MM buyout)
San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.
Outrights: Padlo, Beckham
A couple updates on some recent DFAs to kick off the morning…
- Infielder Kevin Padlo cleared outright waivers and was assigned to Triple-A Indianapolis, the Pirates announced Monday. He has neither a prior outright assignment nor three years of Major League service time, so he won’t have the option of rejecting the assignment. The 26-year-old corner infielder was hitless in 11 plate appearances with the Bucs this year and carries a dismal .109/.163/.152 slash in the Majors on the whole — although that’s come in a tiny sample of just 49 plate appearances. Padlo is a .251/.336/.484 hitter at the Triple-A level (836 plate appearances) and ranked among the top 25 prospects of the Rockies, Rays and Mariners over the past five offseasons, per Baseball America.
- Twins infielder Tim Beckham went unclaimed on waivers and was assigned outright to Triple-A, per the team’s transactions log at MLB.com. Beckham went just 2-for-25 in his limited time with Minnesota but has posted a comical .413/.483/.579 slash with five homers and six doubles in 143 trips to the plate with Triple-A St. Paul so far in 2022. Beckham, who carries a .247/.299/.426 slash in 1776 Major League plate appearances with four different teams, has played all four infield positions in the minors this season and also logged four games in left field with the big league club. He has more than five years of big league service, which would allow him to reject this assignment and look for another opportunity if he desires.
Twins Do Not Expect Kenta Maeda To Return During Regular Season
It’s unlikely the Twins will welcome back Kenta Maeda from the injured list during the regular season, chief baseball officer Derek Falvey informed reporters (including Phil Miller of the Minneapolis Star-Tribune and Do-Hyoung Park of MLB.com). While Maeda hasn’t suffered any kind of setback, it seems the organization is just running out of time to get him back on a major league mound.
Maeda underwent an internal brace Tommy John surgery last September, making it viable that he’d miss the entire 2022 campaign. He and the Twins had expressed hope he’d be able to make it back to the mound in September this year, with the internal brace procedure having a slightly more expedited recovery timeline (around 9-12 months) than a typical complete UCL reconstruction. Maeda has been throwing bullpen sessions but hasn’t yet started out on a minor league rehab assignment. He’d surely need multiple weeks to build back up in the minors, and with just five weeks remaining in the regular season, the Twins are apparently disinclined to push him back.
The mention of Maeda not returning in the regular season at least leaves open the possibility of a playoff comeback. Minnesota sits two games back of the Guardians in the AL Central race. They’re firmly in the mix for a postseason spot but far from a lock, so it’s possible Maeda won’t have any playoff games to target. If the Twins do reach the postseason, that’d extend the window for his potential return, although there’d be real risk in installing a player who hasn’t thrown a big league pitch in 14 months directly into a playoff series. It seems more likely that 2022 will wind up going down as a lost year entirely for Maeda. He’s under contract for a modest $3MM next season, and the Twins will presumably pencil him into the season-opening rotation if he has a normal offseason.
While the news on Maeda is a bit discouraging, the Twins provided positive updates on both right-hander Bailey Ober and outfielder Trevor Larnach (Park links). Ober, who has been out since June 1 with a groin strain, is set to begin a rehab assignment on Thursday. The club plans to deploy him as a multi-inning reliever for the stretch run, as building him back to starting would require too lengthy a rehab stint. Larnach, who has been out since undergoing core muscle surgery in late June, is also expected to start a rehab assignment this week.
Twins Designate Tim Beckham For Assignment
The Twins announced Friday that they’ve reinstated outfielder Kyle Garlick from the 10-day injured list and designated infielder Tim Beckham for assignment in order to open a spot on the roster.
Beckham, 32, inked a minor league deal with the Twins over the winter and recently had his contract selected as Minnesota deals with a deluge of injuries both in the outfield and around the infield. He appeared in a dozen games with the Twins but took just 25 plate appearances and went 2-for-25 with nine strikeouts in that time.
Beckham has had a monster season in Triple-A, hitting .413/.481/.579 in 133 plate appearances, but it was never particularly realistic to expect the journeyman to sustain anything close to that level of output in the big leagues, where he’s a .247/.299/.426 hitter in 1776 plate appearances. He’ll be placed on waivers or released within the coming days now that he’s been designated for assignment.
Garlick, 30, will give the Twins a much-needed healthy outfielder and some desperately needed help against left-handed pitching. He’s hitting .257/.319/.514 in 116 plate appearances this year and has carved out a role with the Twins based on his ability to clobber southpaws. In 172 career plate appearances against lefties, the right-handed-hitting Garlick is a .266/.314/.576 hitter.
Twins Sign Billy Hamilton To Minor League Deal
The Twins have signed veteran outfielder Billy Hamilton to a minor league contract, according to multiple reporters (including The Athletic’s Dan Hayes). Hamilton elected to become a free agent earlier this month, rejecting an outright assignment to the Marlins’ Triple-A team.
Minnesota becomes the 11th different big league organization of Hamilton’s 10-year MLB career, and he has been action at the big league level with seven of those teams. Hamilton’s stint in Miami lasted 20 games and consisted of 15 plate appearances, as the Marlins mostly used him as a pinch-runner and late-game defensive replacement.
It’s safe to assume that Hamilton will be utilized in similar fashion with the Twins if he reaches their active roster, and the 31-year-old will at least provide some center field depth now that Byron Buxton has been placed on the 10-day injured list. Hamilton’s lack of hitting has turned him into a bench player in recent years, but he still brings plenty of his signature speed and excellent defense, making him a sought-after player by multiple teams.
Outfelders Buxton, Kyle Garlick, Trevor Larnach, Alex Kirilloff, and Royce Lewis are all on Minnesota’s IL, with Garlick perhaps only a few days away from a return and Kirilloff and Lewis both already done for the season. Max Kepler, Nick Gordon, Jake Cave, Gilberto Celestino, and utilityman Tim Beckham comprise the Twins’ outfield options on the active roster.
Twins Place Byron Buxton On Injured List
The Twins announced they’ve placed center fielder Byron Buxton on the 10-day injured list due to a low-grade right hip strain. Catcher/infielder Caleb Hamilton was recalled from Triple-A St. Paul to take his spot on the active roster. The club also confirmed the previously-reported selection of righty Aaron Sanchez to start tonight’s ballgame against the Astros, with lefty Devin Smeltzer optioned to St. Paul. Corner outfielder Alex Kirilloff, who is out for the season after undergoing wrist surgery this month, was transferred to the 60-day injured list to open a 40-man roster spot for Sanchez.
Buxton left last night’s contest with soreness in the hip, and manager Rocco Baldelli told reporters after the game that the issue had nagged at the star outfielder for much of the season (via Aaron Gleeman of the Athletic). The club announced he’d head for an MRI today. Darren Wolfson of SKOR North reports that the MRI didn’t reveal any serious issues, seemingly backed up by the team’s specification of a “low-grade” strain. It’ll nevertheless cost Buxton at least a week and a half of action.
It’s the second consecutive season in which Buxton has landed on the IL due to a right hip strain. His previous hip injury, suffered while running the bases, cost him nearly six weeks between May and June 2021. There’s no indication this issue is expected to be that severe — it seems unlikely given the generally optimistic tenor of the club’s prognosis — but even a couple weeks without the first-time All-Star will be a tough blow for a Minnesota team that is two games back of the Guardians in the AL Central and three games out of the American League’s final Wild Card spot.
In addition to the hip discomfort that has apparently plagued Buxton on and off all season, the club has been cautious with his workload as he nursed some soreness in his right knee. Being more judicious with his playing time had seemingly helped Buxton avoid an IL stint for the knee concerns, but he’ll land on the shelf for the first time all season with the hip issue. He’s spent some time on the IL in every year since 2017, but he’s continued to electrify when physically able to take the field. Buxton earned the first All-Star nod of his career this summer, and he’s blasted 28 home runs in 92 games. He’s hitting just .224 with a .306 on-base percentage, but the combination of his prodigious power and otherworldly center field defense has made him one of the game’s top outfielders.
Twins To Select Aaron Sanchez
The Twins are planning to promote righty Aaron Sanchez to start tomorrow evening’s game against the Astros, tweets Do-Hyoung Park of MLB.com. Minnesota will need to formally select Sanchez’s contract tomorrow. The 40-man roster is currently full, although the Twins could easily create a vacancy by transferring Alex Kirilloff to the 60-day injured list after the revelation the outfielder will miss the remainder of the 2022 season. Park adds that left-hander Devin Smeltzer will be optioned to free an active roster spot.
Sanchez has bounced on and off teams’ rosters a few times this season. The sinkerballer signed a minor league deal with the Nationals and was added to the big league roster in mid-April. He was hit hard over seven starts, posting an 8.33 ERA across 31 1/3 innings. Sanchez was released and caught on with Minnesota on a minor league deal. He spent a couple months in Triple-A St. Paul, was brought to the big leagues for a one-off spot start, then again designated for assignment. Sanchez cleared outright waivers and accepted an assignment back to St. Paul, and he’ll now return to the major league club a bit less than three weeks later.
Grisly as his numbers have been in the big leagues this season, the 2016 AL ERA leader has held his own in the upper minors. He allowed only six runs in 15 innings in the Washington system before being called up, and he owns a 3.80 ERA over ten starts with St. Paul. Sanchez has only struck out 16.3% of batters faced over that stretch, but he’s not issued many walks and has a capable 44.8% ground-ball rate.
It remains to be seen whether Sanchez’s second stay on the Twins roster proves more lasting than his initial stint. Minnesota placed deadline acquisition Tyler Mahle on the 15-day injured list over the weekend, leaving an opening in the rotation behind Sonny Gray, Joe Ryan, Chris Archer and Dylan Bundy. The club has Cole Sands as a potential depth option on the active roster, but he’s worked in shorter relief stints of late. Smeltzer has picked up 12 starts this year but not gotten out of the fourth inning in any of his last three outings, and he’ll now head back to Triple-A.
Twins Place Tyler Mahle On 15-Day Injured List
The Twins have placed right-hander Tyler Mahle on the 15-day injured list (retroactive to August 18) due to right shoulder inflammation. Southpaw Devin Smeltzer has been called up to take Mahle’s spot on the active roster.
The IL placement isn’t a big surprise, after Mahle left Wednesday’s game after only 2 1/3 innings, and the Twins already announced that Mahle’s next turn in the rotation would be skipped. On the brighter side, an MRI didn’t reveal any structural damage, and Mahle also told reporters (including Betsy Helfand of the St. Paul Pioneer Press) yesterday that he was feeling better and was able to left weights two days removed from his early exit.
Ideally, Mahle will be able to return when first eligible to be activated off the 15-day IL. Of course, losing the righty for any amount of time is a tough beat for a Minnesota club that is battling for both the AL Central lead or at least a wild card berth. Mahle was supposed to be a big part of this postseason push, acquired from the Reds in a major deal at the trade deadline — thus far, Mahle has a strong 2.51 ERA over his first 14 1/3 innings in a Twins uniform.
Smeltzer could be the likeliest candidate to fill Mahle’s rotation spot, assuming that the Twins pick one single pitcher to cover those starts. The advanced metrics aren’t fans of Smeltzer’s work this season, but the left-hander has managed to outperform those peripherals and post a 4.02 ERA over 12 starts and 62 2/3 frames. If not Smeltzer, the Twins could also turn to Aaron Sanchez or Cole Sands, or possibly a combination of these pitchers in a piggyback situation.
AL Notes: Yankees, Stanton, Blue Jays, Mayza, Twins, Maeda
Giancarlo Stanton is beginning a rehab assignment today, per Lindsey Adler of The Athletic (via Twitter). Before this latest injury, Stanton had been enjoying a run of sound health. For the season, Stanton has appeared in 80 games, slashing .228/.309/.498 with 24 home runs in 328 plate appearances. Stanton even started 38 games in the outfield grass, his most defensive action since 2018. Elsewhere around the Junior Circuit…
- Blue Jays southpaw Tim Mayza will begin a rehab assignment in Triple-A today, per Keegan Matheson of MLB.com (via Twitter). Mayza has been a key piece of Toronto’s bullpen for a number of years, no less so this season when he has pitched to a 2.88 ERA/3.94 FIP across 41 appearances totaling 34 1/3 innings. Mayza has been out of action since August 7th. The 30-year-old has held lefties to a .157/.218/.275 line this season.
- The Twins are cautiously optimistic that Kenta Maeda might be able to return late in the season to pitch out of the bullpen as he used to for the Dodgers. Maeda is throwing bullpens now, but President of Baseball Ops Derek Falvey was non-commital about Maeda’s ability to make a late-season appearance, per Darren Wolfson of 5 Eyewitness News (via Twitter). Maeda is recovering from Tommy John surgery.
Big Hype Prospects: Grissom, Walker, Holliday, Lee, Painter
This week on Big Hype Prospects, we check in with a couple recently-promoted Major Leaguers, peek at a couple more on the cusp, and introduce ourselves to some hot-hitting 2022 draftees.
Five Big Hype Prospects
Vaughn Grissom, 21, 2B/SS, ATL (MLB)
35 PA, 2 HR, 2 SB, .406/.457/.656
Grissom was just playing his way into consensus Top 100 status when the Braves tabbed him for a Major League promotion instead. He had just 98 plate appearances in Double-A after spending much of the season in High-A (344 PA, 11 HR, 20 SB, .312/.404/.487). His numbers have actually improved slightly at each stop. As many have noted (unpleasant noise warning), he’s the second player the Braves have skipped straight past Triple-A. Of course, 35 plate appearances is hardly the basis for Major League success – the true challenge is proving the ability to counter-adjust once the league figures him out. We might not get to that point since Ozzie Albies is approaching a rehab assignment. Grissom will probably hold down the fort until then.
His arrival also has long-term implications. He mostly played shortstop in the minors. So too did Albies back in the day. The club could be using this opportunity to further their postseason bid by using a more dynamic player than Ehire Adrianza while at the same time assessing if a shortstop signing is an urgent need this winter. If they like what they see from Grissom, the Braves might opt to target a lesser free agent like Jose Iglesias or even skip the market altogether.
Jordan Walker, 20, 3B, STL (AA)
430 PA, 15 HR, 17 SB, .310/.393/.522
On Thursday, Walker had his third double-dinger game since July 29. He appears to have accomplished all that he can in Double-A by both improving upon his walk and strikeout rates while continuing to punish the baseball. One of the big impending storylines of free agency is Nolan Arenado’s player option decision. Will he stay or hit the open market? Judging by the ascendancy of Walker, St. Louis might be alright with letting Arenado walk. After all, they can always use Nolan Gorman at third base if Walker isn’t ready in early 2023.
There are still some issues with Walker’s game hidden underneath the beautiful surface level stats. For one, he has a 16.1 percent swinging strike rate. That’s roughly on par with Adolis Garcia, Ryan Mountcastle, Jorge Mateo, and Patrick Wisdom – not exactly the most contact-oriented collection of batters. Moreover, Walker has these whiff issues while running a 45 percent ground ball rate. One of the “tricks” for striking out less is to flatten a swing plane. That adds grounders at the expense of fly balls. Walker has nothing left to give on that front. For what it’s worth, some of the next guys up on the swinging strike rate list are Julio Rodriguez, Teoscar Hernandez, Rafael Devers, and Byron Buxton. Stars can sometimes have whiff problems without dreadful strikeout rates.
Jackson Holliday, 18, SS, BAL (CPX)
6-for-15, 1 HR, 1 SB, 5 BB, 1 K
The number one overall pick of the 2022 draft, Holliday arrived with a bang in the complex league this week. He hit his first professional home run on Friday and has a five-to-one walk-to-strikeout ratio. MLB Pipeline already rates him the 14th-best prospect in the league – an aggressive ranking compared with the recent updates from Baseball America (39) and Keith Law (42). Scouting notes on Holliday remain sparse, mostly focusing on his excellent pre-draft conditioning as well as a need to see him against more advanced competition. With the way he’s playing in his first week, a promotion could come soon.
Brooks Lee, 21, SS, MIN (A+)
30 PA, 1 HR, .333/.400/.444
Another recent first-round draftee, Lee made short work of the complex league. The Twins liked his hit tool so much they assigned him straight to High-A. There, he’s more than held his own albeit with more swing-and-miss than expected. Given the aggressive assignment – nearly every player in High-A has years rather than a few scant weeks of professional experience – Lee’s early success is encouraging. Law believes Lee “is the ne plus ultra” of fast-moving college draftees, meaning we could see him broach the Majors as early as next season. Law also considers a move to third base likely while other sources think Lee can stick at shortstop so long as he’s well-positioned.
The ”fast-mover” middle infield profile typically consists of a near-elite hit tool and nonexistent power. Think Nick Madrigal. Lee’s power is more aptly described as nascent. He’s expect to grow into 10 to 20 home runs annually to go with a disciplined, high-average approach.
Andrew Painter, 19, SP, PHI (A+)
(A+) 36.2 IP, 12.03 K/9, 1.72 BB/9, 0.98 ERA
Last week, we covered Ricky Tiedemann in this spot. Many of the same superlatives apply to Painter. He’s the same age as Tiedemann and rapidly ascending towards Top 10 prospect status. He’s one of the best pitchers left in the minors. At present, Painter has a fastball-slider combo that evokes Spencer Strider. Painter lives upstairs with 98-mph heat then drops sharp sliders into the strike zone. Scouting reports indicate his ability to locate the slider outside of the zone is still a work in progress as are the development of a curve and changeup. Given Strider’s success with the same toolkit, Painter might just find his way to the Majors next season as a two-pitch 20-year-old.
Five More
Josh Jung, TEX (24): Last week, we noted Jung’s successful return to Triple-A. Since then, he’s gone 10-for-20 with four home runs, three doubles, two walks, and a strikeout. A promotion should come any day now.
Sal Frelick, MIL (22): Speaking of hot bats, Frelick is hitting .440/.525/.540 through his first 60 Triple-A plate appearances with more walks than strikeouts. The Brewers have fallen three games behind the Cardinals in the NL Central and two games back of the Phillies in the Wild Card race. Milwaukee could consider taking a page from the Braves by promoting Frelick before he’s ticked all the usual developmental boxes. Center field and leadoff hitter are their biggest areas of need. Frelick profiles as Steven Kwan-like.
Brayan Bello, BOS (23): Bello is slated to make a rehab start at Triple-A on Friday. If all goes well, he could return to the Majors in short order. While it’s trendy to count the Red Sox out of the playoff hunt, they’re only five games behind the Rays and Jays. They’re six back of the Mariners. A recovery is certainly possible. Bello, with his domineering stuff and over-60 percent ground ball rate, could be an important piece if Boston is to salvage their season.
Kerry Carpenter, DET (24): A late-bloomer who only started generating hype this season, Carpenter thrashed the upper-minors for 30 home runs in 400 plate appearances. He’s since tacked on two dingers in 25 Major League plate appearances. As expected, he’s shown signs of below average plate discipline and a modest swinging-strike issue in his small sample of big league experience. Overall, his debut has been a rousing success to date so the Tigers have every reason to continue trotting him out on a daily basis.
Marcelo Mayer, BOS, (19): In recent years, we’ve been spoiled with precocious play from young, top prospects. Of all the Top 10 prospect candidates, we’ve had the least to say about Mayer in this column. The long and short of it is he’s having a typical season for a prospect of his age and repute. He hasn’t done anything jaw-dropping while at the same time assuring onlookers of his eventual role as a Major League shortstop of some quality. Personally (remember, I’m not a scout), I see similarities to J.P. Crawford with eventual power outcomes being a tad more accessible/plausible. Since a recent promotion to High-A, he’s hitting .243/.333/.405 in 42 plate appearances.